Drugdiscovery >> Drugs >> News
13709
Views
title
New erectile dysfunction drug approved in Ireland and the Netherlands - drugdiscovery.com


Apricus Biosciences has been granted marketing authorization for Vitaros(R) indicated for the treatment of patients with erectile dysfunction. It is already approved in Sweden and the United Kingdom and authorization applications are being pursued in another six European countries.
Read More >>


Tags: Vitaros, Apricus Biosciences, erectile dysfunction, approval, marketing authorization - August 16, 2013
Related Articles
1590
Views
Fake erectile dysfunction pills appeared in Czech Republic Fake erectile dysfunction pills appeared in Czech Republic
Almost 200,000 fake erectile dysfunction pills (Viagra and Cialis) which arrived from an unspecified country in southern Asia have been seized by Czech customs officials. Read More >>

Tags: erectile dysfunction, pills, fake, Czech Republic, southern Asia, viagra, Cialis

3460
Views
Can back pain medication cause erectile dysfunction? Can back pain medication cause erectile dysfunction?
A large US study shows that men who are prescribed opioid drugs for back pain more often require medications for erectile dysfunction and testosterone depletion than those who have not taken the drugs Read More >>

Tags: back pain, medication, opioids, erectile dysfunction, testosterone, depletion

10836
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

15278
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

14122
Views
Bayer’s new hypertension drug to be approved by FDA Bayer’s new hypertension drug to be approved by FDA
The new drug worked well in clinical trials and is recommended for approval but at lower doses than those proposed by the company. Read More >>

Tags: Bayer, new drug, hypertension, pulmonary hypertension

8501
Views
Takeda's schizophrenia drug lurasidone approved in Swiss Takeda's schizophrenia drug lurasidone approved in Swiss
This is the first approval in Europe for lurasidone, which is already marketed as Latuda for schizophrenia and bipolar depression in the US and Canada. Read More >>

Tags: lurasidone, latuda, drug, schizophrenia, bipoloar disorder, Swiss, approval, Europe

12433
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

7956
Views
Astellas’ diarrhea drug - Irribow approved in Japan Astellas’ diarrhea drug - Irribow approved in Japan
Astellas Pharma announced the approval of the additional formulation of Irribow OD Tablets for treatment of diarrhea-predominant irritable bowel syndrome in Japan. Read More >>

Tags: Irribow, Astellas, diarrhea, irritable bowel syndrome, approval

7678
Views
Novartis’ COPD treatments approved in EU and Japan Novartis’ COPD treatments approved in EU and Japan
Ultibro Breezhaler has been approved by the European Commission as a maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease (COPD). Ultibro Inhalation Capsul Read More >>

Tags: Ultibro, COPD, drug, Novartis, approval, EU, Japan

12666
Views
Teva’s drug for treating neutropenia approved in EU Teva’s drug for treating neutropenia approved in EU
Teva got EU market authorization for the drug Lonquex (lipegfilgrastim) , which is used for reduction of the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing c Read More >>

Tags: Teva, lonquex, Neulasta, EMA, EU, approval,febrile neutropenia, neutropenia, cancer patients, patients undergoing chemotherapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013